BRANFORD, Conn.–(BUSINESS WIRE)–Nov. 9, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced financial results for the third quarter ended September 30, 2023. Third Quarter Highlights Recorded revenue of $223,000 in the third quarter of 2023 as the Company continued its previously communicated controlled commercial launch of its […]

BRANFORD, Conn.–(BUSINESS WIRE)–Nov. 8, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced it has received the “Proteomics Company of the Year” award from the BioTech Breakthrough Awards as part of the program’s 2023 award recipients for its first of a kind protein sequencing instrument. “Since the groundbreaking […]

BRANFORD, Conn.–(BUSINESS WIRE)–Nov. 1, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in two upcoming investor conferences: Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum 6th Annual Evercore ISI HealthCONx Conference About the Canaccord Genuity MedTech Diagnostics and Digital Health […]

BRANFORD, Conn.–(BUSINESS WIRE)–Oct. 31, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced it will showcase next-generation benchtop protein sequencing instrument, Platinum™, and the Company’s vision to transform genomics and proteomics research, at the American Society of Human Genetics (ASHG) conference, in Washington, D.C., November 1-5. “Platinum, stands […]

BRANFORD, Conn.–(BUSINESS WIRE)–Oct. 17, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will report financial results for the third quarter 2023 on Thursday, November 9, 2023. Company management will host a conference call to discuss financial results and provide a business update on the same […]

Remarks from Senior Vice President of Product Development John Vieceli will highlight the Company’s scalable next-generation Protein Sequencing™ technology to analyze the proteome with single amino acid resolution BRANFORD, Conn.–(BUSINESS WIRE)–Oct. 3, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the Company and Senior Vice President of […]

BRANFORD, Conn.–(BUSINESS WIRE)–Sep. 21, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Amir Jafri, President and CEO of Immunicom, Inc., to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230921747791/en/ (Photo: Business Wire) “Amir’s leadership track record speaks […]

BRANFORD, Conn.–(BUSINESS WIRE)–Aug. 22, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Platinum™, the world’s first next-generation protein sequencing instrument, has been honored in Fast Company’s Innovation by Design Awards for 2023 in the Products category. The Innovation by Design Awards, which can be found in […]

BRANFORD, Conn.–(BUSINESS WIRE)–Aug. 16, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted a non-qualified stock option award to purchase an aggregate of 200,000 shares of its Class A common stock to one new employee under the […]

BRANFORD, Conn.–(BUSINESS WIRE)–Aug. 14, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted non-qualified stock option awards to purchase an aggregate of 739,750 shares of its Class A common stock to 8 new employees under the Company’s […]